Sildenafil and Big Pharma: A Risky Venture?

The legacy of Viagra and its influence on the pharmaceutical landscape presents a thorny question for investors . Initially a massive drug, generics have significantly eroded its market dominance, creating obstacles for companies connected to the original patent holder and related advancements . While certain businesses might profit from focused Vi

read more